Stocks ONCO

Onconetix, Inc. Effects 1:10 Reverse Stock Split

Onconetix, Inc. filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on November 4, 2026, to effect a one-for-ten (1:10) reverse stock split of its issued and outstanding common stock. The reverse stock split became effective at 12:01 a.m. Eastern Time on November 6, 2026. The Board of Directors of the company previously approved the split on October 22, 2026, pursuant to authority granted by stockholders at a special meeting held on April 30, 2026.

Pursuant to the amendment, every ten (10) shares of the company's issued and outstanding common stock were automatically combined into one (1) issued and outstanding share of common stock, without any corresponding reduction in the number of authorized shares or any change in the par value per share. No fractional shares were issued, and stockholders who otherwise would have been entitled to receive a fractional share will instead receive a cash payment. As a result of the reverse stock split, the number of outstanding shares of common stock was reduced from approximately 6.7 million shares to approximately 670,000 shares. Proportional adjustments were made to the number of shares issuable upon exercise or conversion of outstanding equity awards, convertible preferred stock, and warrants.

The common stock began trading on a split-adjusted basis on The Nasdaq Capital Market on November 6, 2026, under the company's existing trading symbol ONCO and a new CUSIP number, 68237Q500.

View the company filing on SEC.gov

Take Fintel with you. Download the Fintel app from the App Store or Google Play.

This story originally appeared on Fintel.

Fintel
Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford.
Check out our Unique Analysis of Insider Sentiment for Onconetix, Inc. Find out what the Options Markets think of Onconetix, Inc. See our take on Onconetix, Inc. Upcoming Earnings More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available